HIV/AIDS Vaccine: An Update

According to mathematical estimates by the International AIDS Vaccine Initiative (IAVI) - provided that other programs for treatment and prevention have been scaled up - an HIV vaccine with an efficacy as low as 30% and coverage as low as 20% could avert as many as 5.5 million new infections between...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of community medicine Vol. 35; no. 2; pp. 222 - 225
Main Author Nath, Anita
Format Journal Article
LanguageEnglish
Published India Medknow Publications and Media Pvt. Ltd 01.04.2010
Medknow Publications & Media Pvt. Ltd
Medknow Publications
Wolters Kluwer Medknow Publications
Subjects
Acquired immune deficiency syndrome
AIDS
AIDS vaccines
CME
Deoxyribonucleic acid
DNA
Forecasts and trends
Genetic diversity
HIV
Human immunodeficiency virus
Immune system
International aspects
Medical research
Pharmaceutical industry
Prevention
Prevention programs
Product development
Public health
Sexually transmitted diseases
Studies
Vaccines
India
Online AccessGet full text

Cover

More Information
Summary:According to mathematical estimates by the International AIDS Vaccine Initiative (IAVI) - provided that other programs for treatment and prevention have been scaled up - an HIV vaccine with an efficacy as low as 30% and coverage as low as 20% could avert as many as 5.5 million new infections between the years 2015 and 2030. [...] it helps to avoid unnecessary wastage of resources.Phase III:
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0970-0218
1998-3581
DOI:10.4103/0970-0218.66862